Problems Associated with Biological Markers of Alzheimer’s Disease

By Frey H. J.   Mattila K. M.   Korolainen M. A.   Pirttilä T.  

Neurochemical Research, Vol. 30, Iss. 12, 2005-12 ,pp. : 1501-1510

Springer Publishing Company

Access to resources Recommend Favorite

Antioxidant treatment in alzheimer’s disease: Current state

By Gilgun-Sherki Yossi   Melamed Eldad   Offen Daniel  

Journal of Molecular Neuroscience, Vol. 21, Iss. 1, 2003-09 ,pp. : 1-11

Humana Press, Inc

Access to resources Recommend Favorite

Immunological approach for the treatment of Alzheimer’s disease

By Solomon Beka  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 283-286

Humana Press, Inc

Access to resources Recommend Favorite

Possible treatment targets in Alzheimer’s disease

By Pryce Roberts A.   Robertson N.  

Journal of Neurology, Vol. 260, Iss. 12, 2013-12 ,pp. : 3193-3196

Springer Publishing Company

Access to resources Recommend Favorite

Somatic comorbidities and Alzheimer’s disease treatment

By Clodomiro Alessandra   Gareri Pietro   Puccio Gianfranco   Frangipane Francesca   Lacava Roberto   Castagna Alberto   Manfredi Valeria   Colao Rosanna   Bruni Amalia  

Neurological Sciences, Vol. 34, Iss. 9, 2013-09 ,pp. : 1581-1589

Springer Publishing Company

Access to resources Recommend Favorite